Clinical Trial Update: Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial evaluating blood-brain barrier disruption using Cerezyme (imiglucerase) in Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CEREZYME (imiglucerase)

Snippet

Sponsor: InSightec | Conditions: Parkinson Disease | NA | Status: COMPLETED